The Wall Street Journal says the U.S. Justice Department in recent months has launched an investigation into UnitedHealth Group’s billing practices to see if the company fraudulently used diagnosis ...

The selloff came as more than $2.7 trillion worth of options expired, an event which typically spurs heightened volatility.

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.